- Home
- ERAS vs FSBW Comparison
ERAS vs FSBW Comparison
Compare ERAS & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- FSBW
- Stock Information
- Founded
- ERAS 2018
- FSBW 1936
- Country
- ERAS United States
- FSBW United States
- Employees
- ERAS N/A
- FSBW N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- FSBW Banks
- Sector
- ERAS Health Care
- FSBW Finance
- Exchange
- ERAS Nasdaq
- FSBW Nasdaq
- Market Cap
- ERAS 348.4M
- FSBW 303.1M
- IPO Year
- ERAS 2021
- FSBW 2012
- Fundamental
- Price
- ERAS $1.45
- FSBW $42.09
- Analyst Decision
- ERAS Strong Buy
- FSBW Hold
- Analyst Count
- ERAS 6
- FSBW 1
- Target Price
- ERAS $4.83
- FSBW $44.00
- AVG Volume (30 Days)
- ERAS 1.2M
- FSBW 17.4K
- Earning Date
- ERAS 08-11-2025
- FSBW 07-22-2025
- Dividend Yield
- ERAS N/A
- FSBW 2.61%
- EPS Growth
- ERAS N/A
- FSBW N/A
- EPS
- ERAS N/A
- FSBW 4.31
- Revenue
- ERAS N/A
- FSBW $139,608,000.00
- Revenue This Year
- ERAS N/A
- FSBW $8.42
- Revenue Next Year
- ERAS N/A
- FSBW $6.09
- P/E Ratio
- ERAS N/A
- FSBW $9.95
- Revenue Growth
- ERAS N/A
- FSBW 0.22
- 52 Week Low
- ERAS $1.01
- FSBW $34.61
- 52 Week High
- ERAS $3.45
- FSBW $49.15
- Technical
- Relative Strength Index (RSI)
- ERAS 52.19
- FSBW 69.28
- Support Level
- ERAS $1.38
- FSBW $41.58
- Resistance Level
- ERAS $1.58
- FSBW $43.25
- Average True Range (ATR)
- ERAS 0.11
- FSBW 0.86
- MACD
- ERAS 0.01
- FSBW 0.39
- Stochastic Oscillator
- ERAS 64.86
- FSBW 88.32
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.